28 July 2023

Field Safety notification regarding medical devices and pharmaceutical products

Reference: CIR-2023-00000131

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

Voluntary Recall of Five Lots of the Pharmaceutical Product VAXNEUVANCE

Voluntary Recall of Two Lots of the Pharmaceutical Product Sabril 500 mg

Circular No. 6583 for the year 2023 regarding field safety corrective actions

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

VAXNEUVANCE +.pdf:

View Document

Sabril 500 mg Tablets +.pdf:

View Document

تقارير سلامة الوسائل الطبية 25-7 -2023 ---.pdf:

View Document